Transactions
Dec. 18, 2001
Dewey Ballantine: MEDIMMUNE BUYS MAKER OF NASAL SPRAY FLU VACCINE
MedImmune Inc. announced Dec. 2 its acquisition of Aviron. The deal was worth $1.5 billion in stock. Gaithersburg, Md.-based MedImmune develops and sells vaccines. The company's signature product, Synagis, is a vaccine used to prevent pneumonia and bronchitis in infants.




Gaithersburg, Md.-based MedImmune develops and sells vaccines. The company's signature product, Synagis, is a vaccine used to prevent pneumonia and bronchitis in infants.
Mountain View's Aviron develops vaccines using live v...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In